Cargando…
Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood
OBJECTIVE: Although type 1 diabetes autoimmunity frequently begins in childhood, little is known about the relationship between age and autoimmunity development. Our aim was to determine the timing of seroconversion to diabetes-associated autoantibody (DAA) positivity and risk in first- and second-d...
Autores principales: | Vehik, Kendra, Haller, Michael J., Beam, Craig A., Schatz, Desmond A., Wherrett, Diane K., Sosenko, Jay M., Krischer, Jeffrey P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024349/ https://www.ncbi.nlm.nih.gov/pubmed/21270193 http://dx.doi.org/10.2337/dc10-1494 |
Ejemplares similares
-
Development of Autoantibodies in the TrialNet Natural History Study
por: Vehik, Kendra, et al.
Publicado: (2011) -
Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial
por: Vehik, Kendra, et al.
Publicado: (2011) -
A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants
por: Sosenko, Jay M., et al.
Publicado: (2011) -
Feature ranking based on synergy networks to identify prognostic markers in DPT-1
por: Adl, Amin Ahmadi, et al.
Publicado: (2013) -
Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009)